UPDATED 6:11 PM PT – Thursday, December 8, 2022
The Food and Drug Administration (FDA) has changed their emergency use authorization (EUAs) for COVID vaccines to now include children from five years to six-months-old.
The agency’s top vaccine regulator Peter Marks announced the emergency use authorization of an updated bivalent COVID-19 vaccine early on Thursday.
This comes after Pfizer and BioNTech sought an authorization from the agency on Monday for the vaccine’s use in children under the age of five.
The FDA currently recommends children to receive three shots of the COVID-19 vaccine. They reportedly expects to receive the data needed to support a fourth dose in January.
CDC data shows only 6.4% percent of children under two have received at least one dose of a COVID vaccine.